Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Are China's Rising Labor Costs Good For Big Pharma?

This article was originally published in PharmAsia News

Executive Summary

HONG KONG - Rising labor costs are putting stress on manufacturing operations in China, but may prove to be a boon in the long term for companies focused on the world's fastest-growing domestic market

You may also be interested in...



Rising Labor Cost Top Risk For Multinationals In China – AmCham Survey

A slowing economy and regulatory uncertainty loom large for multinationals operating in China. However, companies say rising labor costs impact them more, and acute shortages of qualified employees further complicate the landscape.

European Firms May Shift Away From China Due To Tougher Environment – European Chamber Of Commerce Survey

Survey finds lingering challenges and uncertainty despite – and sometimes because – of new government measures.

After Another Strong Quarter, WuXi Aims To Become Backbone Of China’s Life Science Industry: China Earnings Roundup (Part 1)

Despite a macroeconomic slowdown, China’s leading CRO reported another strong quarter due to increasing demand for R&D services from both international and domestic companies.

Related Content

UsernamePublicRestriction

Register

SC010771

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel